Dupilumab-induced serum sickness-like reaction in a pediatric patient

Dupilumab-induced serum sickness-like reaction in a pediatric patient

Saved in:

Bibliographic Details
Main Authors:	S. Minhaj Rahman, BA, Fahad Ahmed, BA, Carrington Webb, BA, Adel Haque, MD, Nicole Seminara, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	JAAD Case Reports
Subjects:	atopic dermatitis drug adverse effect dupilumab Dupixent serum sickness
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512624004557
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
by: Lauletta G, et al.
Published: (2025-01-01)

Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
by: Filip Rob, et al.
Published: (2025-12-01)

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01)

The Association of Inflammatory Indexes Derived from Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
by: Zhang L, et al.
Published: (2025-01-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01)

A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries
by: Amani Alfalasi, et al.
Published: (2025-12-01)

Efficacy of dupilumab with concomitant topical calcineurin inhibitors treatment for preschool children with atopic dermatitis: a retrospective cohort study
by: Wu Liming, et al.
Published: (2025-12-01)

Modern treatment methods in atopic dermatitis - literature overview
by: Martyna Borowska-Łygan, et al.
Published: (2025-01-01)

Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
by: Eri Uchiyama, et al.
Published: (2025-01-01)

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)
by: Marjolein de Bruin-Weller, et al.
Published: (2022-07-01)

Rituximab-induced serum sickness: Not so uncommon
by: Vikramraj K Jain
Published: (2018-01-01)

Case Report: Severe ophiasis-pattern alopecia areata with concomitant atopic dermatitis in a 5-year-old boy successfully treated with dupilumab
by: Zhendong Wei, et al.
Published: (2025-02-01)

Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study
by: Yanhua Chen, et al.
Published: (2025-01-01)

Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
by: Nicola Lutzu, et al.
Published: (2025-01-01)

Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index
by: Gabriele Di Lorenzo, et al.
Published: (2003-01-01)

Is the Increase in Tumour Markers and Hashimoto’s Thyroiditis an Incidental Event During Dupilumab Treatment? A Case Report
by: Kesheng Lin, et al.
Published: (2025-02-01)

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)

Gut microbiota and plasma metabolites in pregnant mothers and infant atopic dermatitis: A multi-omics studyKey Message
by: Bingqian Du, MA.Sc, et al.
Published: (2025-01-01)

Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis
by: Verónica Sánchez-García, et al.
Published: (2025-02-01)

Correlation of serum Vitamin D levels and disease severity in patients with atopic dermatitis: A hospital-based, cross-sectional study from North India
by: Shreya Malhan, et al.
Published: (2024-12-01)

Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
by: Mohammed Hasosah, et al.
Published: (2025-02-01)

Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years
by: Andreas Wollenberg, et al.
Published: (2024-12-01)

Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
by: C. Grote, et al.
Published: (2025-12-01)

Exploring Social Health in Patients with Atopic Dermatitis: An Observational, Cross-sectional, Questionnaire Based Study on Social Participation and Emotional Support
by: Esmé Kamphuis, et al.
Published: (2025-01-01)

Acute mountain sickness: pathophysiology and prevention
by: PAWEŁ MOCZYDŁOWSKI, et al.
Published: (2025-01-01)

Advancing allergic rhinitis research through phenome-wide association studies: Insights from known genetic loci
by: Xingling Tan, MD, et al.
Published: (2025-01-01)

Effect of dupilumab on otitis media associated with eosinophilic chronic rhinosinusitis
by: Seiichiro Kamimura, et al.
Published: (2025-03-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

STUDY ON DEEP LEARNING MODELS FOR THE CLASSIFICATION OF VR SICKNESS LEVELS
by: Haechan NA, et al.
Published: (2024-12-01)

Determining atopic dermatitis adult patients’ preferences regarding novel systemic treatment
by: Monika Suszynska, et al.
Published: (2025-01-01)

Asthma and Atopic Diseases in Children with Autism Spectrum Disorders
by: Khaled Saad, et al.
Published: (2024-12-01)

Associations of Atopic Dermatitis in Late Adolescence with Occupation, Mental Health, Income from Work and Marital Status: A National Longitudinal Study
by: Grigorios Theodosiou, et al.
Published: (2025-01-01)

Atopic dermatitis in childhood and pubertal development: A nationwide cohort studyCapsule Summary
by: Camilla Lomholt Kjersgaard, MD, et al.
Published: (2025-04-01)

Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: A step towards clinical remission
by: Mona Al-Ahmad, MD, FRCPC, et al.
Published: (2025-02-01)

Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps
by: Shaun J. Kilty, et al.
Published: (2022-04-01)

A Cross-sectional Study to Assess the Association of Minor Criteria of Hannifin and Rajka with Age and Gender in Pediatric Atopic Dermatitis Population
by: Garima Bansal, et al.
Published: (2024-12-01)

Case report: Dupilumab-induced linear psoriasis: a rare presentation
by: Wen Sun, et al.
Published: (2025-01-01)

Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma
by: Kenji Mizumura, et al.
Published: (2025-01-01)

Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life
by: Andrew Blauvelt, et al.
Published: (2022-07-01)